113.7K XNAS Volume
XNAS 31 Mar, 2025 4:00 PM (EDT)
TELA Bio Inc Key Metrics
Default
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
Technically Bearish
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
7Positive10Negative
41.2% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
TELA Bio Inc Stock Price Analysis
Day Price Range | 1.2 (LTP) 1.21.3 LowHigh |
Week Price Range | 1.2 (LTP) 1.11.5 LowHigh |
Month Price Range | 1.2 (LTP) 1.12.6 LowHigh |
52 Week Price Range | 1.2 (LTP) 1.16.5 LowHigh |
TELA Bio Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Miss
TELA Bio Inc's Revenue was lower than average estimate 2 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 46.6% in FY25
Consensus Recommendation
4 ANALYST Recommendations
BUY
The consensus recommendation from 4 analysts for TELA Bio Inc is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get TELA Bio Inc Stock Analysis
TELA Bio Inc stock analysis with key metrics, changes, and trends.
| TELA Bio Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
|---|---|---|---|---|---|
| Annual Revenue | $69.3 M | 18.56% | positive |
| |
| Annual Net Profit | $37.84 M | 18.91% | positive |
| |
| Price to Earning Ratio | -1.28 | - | negative |
| |
| Stock Price | $1.22 | -78.48% | negative |
| |
| Quarterly Revenue | $17.65 M | 3.83% | positive |
| |
| Quarterly Net profit | $9.21 M | 28.56% | positive |
| |
| Mutual Fund Holding | 14.02 % | 4.5% | positive |
| |
| Promoter Share Holding | 10.24 % | 2.41% | positive |
| |
| Institutional Holding | 69.32 % | 22.89% | positive |
| |
Loading data..
TELA Bio Inc - Company Profile
What does TELA Bio Inc do?
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
TELA Bio Inc Management structure
All Gross Remunerations are in USD
TELA Bio Inc Board of directors
All Gross Remunerations are in USD